Implementation of an Antimicrobial Stewardship Program in the Vascular Surgery Ward of a university tertiary care hospital in Pavia, Northern Italy
Author:
Vecchia Marco1, Colaneri Marta1, Sacchi Paolo1, Marvulli Lea Nadia1, Salvaderi Andrea1, Lanza Jessica2, Boschini Stefano2, Ragni Franco2, Marone Piero3, Cutti Sara4, Muzzi Alba4, Marena Carlo4, Calvi Monica5, Scudeller Luigia6, Marone Enrico Maria7, Bruno Raffaele7
Affiliation:
1. Division of Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo 2. Division of Vascular Surgery Unit, Fondazione IRCCS Policlinico San Matteo 3. Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo 4. Medical Direction, Fondazione IRCCS Policlinico San Matteo 5. Pharmacy Unit, Fondazione IRCCS Policlinico San Matteo 6. Scientific Direction, Fondazione IRCCS Policlinico San Matteo 7. Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia
Abstract
Abstract
Purpose.
The commitment of multidisciplinary teams in antimicrobial stewardship programs (ASPs) is often inadequately considered, especially in surgical wards. We wanted to evaluate clinical, microbiological, and pharmacological outcomes before and after the implementation of an ASP in the Vascular Surgery ward of Fondazione IRCCS Policlinico San Matteo, a tertiary care hospital in Pavia, Italy.
Methods.
This was a quasi-experimental quality-improvement study. The antimicrobial stewardship activity was conducted twice a week for 12 months and consisted of both prospective audit and feedback of all the ongoing antimicrobial prescriptions by the infectious diseases’ consultants and educational meetings for the healthcare workers of the Vascular Surgery ward. For comparison between the study periods, Student t test (Mann-Whitney test for skewed distributions) was used for quantitative variables (ANOVA or Kruskall-Wallis for > 2 groups respectively), and Pearson’s chi-squared test (Fisher exact test where appropriate) for categorical variables. 2-tailed tests were used. P-value significance cut-off was 0.05.
Results.
During the 12-month intervention period, among a total number of 689 patients, 186 prescriptions were revised, mostly leading to de-escalating an ongoing antimicrobial therapy (39, 20.97%). A statistically significant reduction in isolates of carbapenem-resistant Pseudomonas aeruginosa (p-value 0.003) and the absence of Clostridioides difficile infections were reported. No statistically significant changes were observed in terms of length of stay and all-cause in-hospital mortality. A significant decrease in the administration of carbapenems (p-value 0.01), daptomycin (p-value < 0.01) and linezolid (p-value 0.43) was registered. A significant reduction in antimicrobial costs was also observed.
Conclusions.
The implementation of a 12-month ASP brought significant clinical and economic results, highlighting the benefits of a multidisciplinary teamwork.
Publisher
Research Square Platform LLC
Reference26 articles.
1. Talebi Bezmin Abadi A, Rizvanov AA, Haertlé T, Blatt NL, ‘World Health Organization Report: Current crisis of antibiotic resistance’, BioNanoScience, vol. 9, no. 4, pp. 778–788, Dec. 2019, doi: 10.1007/s12668-019-00658-4. 2. ‘Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study’;Lambert ML;Lancet Infect Dis,2011 3. Martin-Loeches I, Torres A, Rinaudo M, Terraneo S, de Rosa F, Ramirez P, Diaz E, Fernández-Barat L, Li Bassi GL, Ferrer M, ‘Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms’, J Infect, vol. 70, no. 3, pp. 213–222, Mar. 2015, doi: 10.1016/j.jinf.2014.10.004. 4. Tammer I, Geginat G, Lange S, Kropf S, Lodes U, Schlüter D, Lippert H, Meyer F, ‘Antibiotic consumption and the development of antibiotic resistance in surgical units’, Zentralbl Chir, vol. 141, no. 01, pp. 53–61, Feb. 2016, doi: 10.1055/s-0033-1351087 5. Manuel Vázquez A, Balibrea JM, Ramia JM, ‘Antimicrobial stewardship programs and surgery: What is our role?’, Cir Esp, vol. 97, no. 4, pp. 187–189, Apr. 2019, doi: 10.1016/j.ciresp.2018.07.008.
|
|